University · founded 1873

Vanderbilt University

Nashville, United States · vanderbilt.edu

Manage this page

Citations, last 5 years: 399k
Works, last 5 years: 43.6k
h-index: 1,195
Scientists listed: 4 755
Grants since 2016: 4 121

Grants received

2007–2022 · training · T32

Training Program on Genetic Variation and Human Phenotypes

Nancy J Cox · Vanderbilt University · funded by National Institutes of Health

$112.5k

2007–2022 · training · T32

Training Program on Genetic Variation and Human Phenotypes

Nancy J Cox · Vanderbilt University · funded by National Institutes of Health

$233.1k

2007–2022 · research · R01

Convergence of the Cox-2 and 5-Lipoxygenase Pathways

Claus Schneider · Vanderbilt University · funded by National Institutes of Health

$54.7k

2007–2020 · research · R01

Membrane Protein Structure Elucidation from Limited Magnetic Resonance Data

Jens Meiler · Vanderbilt University · funded by National Institutes of Health

$354.3k

2006–2026 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

Jerri Michelle Rook · Vanderbilt University · funded by National Institutes of Health

$502kReceptor Mechanisms and Signaling

2006–2025 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$235.8k

2006–2021 · research · R01

Computer-Assited Functional Neurosurgery

Benoit M. Dawant · Vanderbilt University · funded by National Institutes of Health

$604.3kNeurological disorders and treatments

2006–2020 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$317.5kDrug Transport and Resistance Mechanisms

2006–2024 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$235.8k

2006–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$507.1kReceptor Mechanisms and Signaling

2006–2027 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

Jerri Michelle Rook · Vanderbilt University · funded by National Institutes of Health

$502kReceptor Mechanisms and Signaling

2006–2026 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

Jerri Michelle Rook · Vanderbilt University · funded by National Institutes of Health

$531.5kReceptor Mechanisms and Signaling

2006–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$507.1kReceptor Mechanisms and Signaling

2006–2027 · research · R01

Neurophysiological Effects of Training in Visual Cognitive Tasks

Christos Constantinidis · Vanderbilt University · funded by National Institutes of Health

$631.2k

2006–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$507.1kReceptor Mechanisms and Signaling

2006–2026 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

Jerri Michelle Rook · Vanderbilt University · funded by National Institutes of Health

$502kReceptor Mechanisms and Signaling

2006–2024 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$235.6k

2006–2024 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$62k

2006–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$563.5kReceptor Mechanisms and Signaling

2006–2024 · research · R01

Structural Dynamics of Multi-drug Transporters

Hassane S Mchaourab · Vanderbilt University · funded by National Institutes of Health

$235k

2006–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$507.1kReceptor Mechanisms and Signaling

2006–2027 · research · R01

Neurophysiological Effects of Training in Visual Cognitive Tasks

Christos Constantinidis · Vanderbilt University · funded by National Institutes of Health

$647.4k

2005–2027 · research · R01

Antidepressants and Intracellular Signaling Linked to BDNF

Lisa M Monteggia · Vanderbilt University · funded by National Institutes of Health

$532.1kNerve injury and regeneration

2005–2025 · research · R01

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$372.7k

2005–2020 · research · R01

Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$361.7k

2005–2022 · research · R01

Multimodal Registration of the Brain's Cortical Surface

Alexandra J Golby · Vanderbilt University · funded by National Institutes of Health

$733.3k

2005–2025 · research · R01

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$361.4k

2005–2021 · research · R01

Muscarinic Receptor Activators as Antipsychotic Agents

P Jeffrey Conn · Vanderbilt University · funded by National Institutes of Health

$392.5kReceptor Mechanisms and Signaling

2005–2027 · research · R01

Antidepressants and Intracellular Signaling Linked to BDNF

Lisa M Monteggia · Vanderbilt University · funded by National Institutes of Health

$532.1kNerve injury and regeneration

2005–2025 · research · R01

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$380.3k

2005–2027 · research · R01

Antidepressants and Intracellular Signaling Linked to BDNF

Lisa M Monteggia · Vanderbilt University · funded by National Institutes of Health

$532.1kNerve injury and regeneration

2005–2025 · research · R01

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$392.9k

2005–2025 · research · R01

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

Ann Richmond · Vanderbilt University · funded by National Institutes of Health

$380k

2005–2027 · research · R01

Antidepressants and Intracellular Signaling Linked to BDNF

Lisa M Monteggia · Vanderbilt University · funded by National Institutes of Health

$532.1k

2004–2020 · training · T32

Surgical Oncology Training Grant

Wael El-Rifai · Vanderbilt University · funded by National Institutes of Health

$61.4kAdvances in Oncology and Radiotherapy

2004–2023 · research · R01

Structural Requirements for Sterol 14alpha-Demethylases

Galina I Lepesheva · Vanderbilt University · funded by National Institutes of Health

$364k

2004–2020 · research · R01

Cognitive and Neural Processes in Reading Comprehension

Laurie E Cutting · Vanderbilt University · funded by National Institutes of Health

$623.6kReading and Literacy Development

2004–2023 · research · R01

Mechanisms of Cell Polarity Establishment

Ian G Macara · Vanderbilt University · funded by National Institutes of Health

$100.1k

2004–2023 · research · R01

Mechanisms of Cell Polarity Establishment

Ian G Macara · Vanderbilt University · funded by National Institutes of Health

$310.8k

2004–2023 · research · R01

Structural Requirements for Sterol 14alpha-Demethylases

Galina I Lepesheva · Vanderbilt University · funded by National Institutes of Health

$24.3k